Interaction of multitargeted tyrosine kinase inhibitors with human nucleoside transporters

被引：0
|
作者：
Damaraju, Vijaya L. [1 ]
Kuzma, Michelle [1 ]
Mowles, Delores [1 ]
Cass, Carol E. [2 ]
Sawyer, Michael B. [1 ]
机构：
[1] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada
[2] Univ Alberta, Edmonton, AB, Canada
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-797
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
797
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Antiangiogenic therapy of cancer by multitargeted tyrosine kinase inhibitors
    Agata, Naoki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 40P - 40P
  • [2] Murine colitis treated with multitargeted tyrosine kinase inhibitors
    Knod, Jennifer Leslie
    Crawford, Kelly
    Dusing, Mary
    Frischer, Jason S.
    JOURNAL OF SURGICAL RESEARCH, 2016, 200 (02) : 501 - 507
  • [3] Multitargeted molecules versus combined tyrosine kinase inhibitors
    Soria, J.
    Deutsch, E.
    Armand, J.
    EJC SUPPLEMENTS, 2006, 4 (12): : 13 - 14
  • [4] Inappropriate dose of multitargeted tyrosine kinase inhibitors: the original sin
    Kotecki, Nuria
    Penel, Nicolas
    CURRENT OPINION IN ONCOLOGY, 2016, 28 (05) : 437 - 440
  • [5] Rational Design of Multitargeted Tyrosine Kinase Inhibitors: A Novel Approach
    Barchechath, Sylvie
    Williams, Christopher
    Saade, Khalil
    Lauwagie, Sylvia
    Jean-Claude, Bertrand
    CHEMICAL BIOLOGY & DRUG DESIGN, 2009, 73 (04) : 380 - 387
  • [6] Thienopyrimidine ureas as novel and potent multitargeted receptor tyrosine kinase inhibitors
    Dai, YJ
    Guo, Y
    Frey, RR
    Ji, ZQ
    Curtin, ML
    Ahmed, AA
    Albert, DH
    Arnold, L
    Arries, SS
    Barlozzari, T
    Bauch, JL
    Bouska, JJ
    Bousquet, PF
    Cunha, GA
    Glaser, KB
    Guo, J
    Li, JL
    Marcotte, PA
    Marsh, KC
    Moskey, MD
    Pease, LJ
    Stewart, KD
    Stoll, VS
    Tapang, P
    Wishart, N
    Davidsen, SK
    Michaelides, MR
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (19) : 6066 - 6083
  • [7] Interactions of Multitargeted Kinase Inhibitors and Nucleoside Drugs: Achilles Heel of Combination Therapy?
    Damaraju, Vijaya L.
    Kuzma, Michelle
    Mowles, Delores
    Cass, Carol E.
    Sawyer, Michael B.
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (01) : 236 - 245
  • [8] Recent Advances in the Discovery of Multitargeted Tyrosine Kinase Inhibitors as Anticancer Agents
    Guo, Ting
    Ma, Shutao
    CHEMMEDCHEM, 2021, 16 (04) : 600 - 620
  • [9] Interaction of nucleoside analogs with the NA(+)-nucleoside transporters in the human intestine
    Patil, SD
    Unadkat, JD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PI59 - PI59
  • [10] Comparison of antitumor effects of multitargeted tyrosine kinase inhibitors in acute myelogenous leukemia
    Hu, Shuiying
    Niu, Hongmei
    Minkin, Patton
    Orwick, Shelley
    Shimada, Akira
    Inaba, Hiroto
    Dahl, Gary V. H.
    Rubnitz, Jeffrey
    Baker, Sharyn D.
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (05) : 1110 - 1120
12345